By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Arena Pharmaceuticals, Inc. 

6166 Nancy Ridge Drive

San Diego  California  92121  U.S.A.
Phone: 858-453-7200 Fax: 858-453-7210


SEARCH JOBS


Industry
Biotechnology


Collaborations

Lexicon Genetics Incorporated 

Merck & Co., Inc.  Cardiovascular





Company News
Biotech Hiring Surge: Trends To Watch; Industry Tips From Arena Pharmaceuticals, Inc. (ARNA) 8/25/2014 3:19:23 AM
Arena Pharmaceuticals, Inc. (ARNA) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/1/2014 7:28:10 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce Publication Of Post-Hoc Analyses Of Lorcaserin Phase 3 Clinical Trial Results In Obesity 7/30/2014 8:22:26 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce BELVIQ® (lorcaserin HCl) CIV Nominated A Second Time For The Prix Galien Award In The Best Pharmaceutical Agent Category 7/29/2014 8:04:43 AM
Arena Pharmaceuticals, Inc. (ARNA) To Host Corporate Update And Financial Results Conference Call And Webcast On Friday, August 1 7/25/2014 9:00:22 AM
Arena Pharmaceuticals, Inc. (ARNA) Enters Into Marketing And Supply Agreement For BELVIQ® (Lorcaserin Hcl) In Israel 7/21/2014 11:56:56 AM
Arena Pharmaceuticals, Inc. (ARNA) Issued Patent For APD371 By United States Patent And Trademark Office 7/16/2014 9:48:14 AM
Arena Pharmaceuticals, Inc. (ARNA) Reports That Eisai Inc. (ESALF.PK) Completes Planned Increase In Sales Force For BELVIQ® (Lorcaserin Hcl) CIV 7/10/2014 10:09:06 AM
Arena Pharmaceuticals, Inc. (ARNA) To Present At The 2014 Wells Fargo Securities Healthcare Conference 6/13/2014 7:05:57 AM
Arena Pharmaceuticals, Inc. (ARNA) Initiates Phase 1b Clinical Trial Of APD334 For Autoimmune Diseases 6/3/2014 9:28:57 AM
12345678910...
//-->